ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KEVIN LOGAN M.D.

Internal Medicine

390

$12.1K

37
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $61

WILLIAM WASHINGTON M.D.

Internal Medicine

1,242

$39.2K

80
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $61

EMILY YOUNG MD

Internal Medicine

895

$34.6K

122
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $61

ROBERT RUSCHE MD

Internal Medicine

11,950

$658K

419
378 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

DOMINICK ACQUARO M.D.

Internal Medicine

2,885

$158K

288
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

ROMANA MALIK

Internal Medicine

1,202

$65.7K

59
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

MARK TIRITILLI

Internal Medicine

10,896

$673K

459
197 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

C. WAIT M.D.

Internal Medicine

8,964

$759K

535
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $61

ALMITRA THOMAS MD

Internal Medicine

1,637

$81.3K

142
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

VERNON VIX MD

Internal Medicine

14,216

$756K

552
438 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

LOIS LAMBRECHT M.D.

Internal Medicine

3,844

$232K

122
84 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

SUSAN KIRAY MD

Internal Medicine

2,485

$114K

163
105 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $61

BRADFORD BOMBA MD

Internal Medicine

18,843

$1.27M

850
747 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

SUDHEER GURRAM MD

Internal Medicine

9,565

$651K

322
216 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

GERRY HIPPENSTEEL M.D.

Internal Medicine

12,390

$620K

437
381 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

LARRY BLEDSOE MD

Internal Medicine

7,790

$462K

246
111 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

54%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

CANDICE FLAUGHER DO

Internal Medicine

3,450

$491K

399
221 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$142
Average prescription price

Avg: $61

JOSEPH MUNNING M.D.

Internal Medicine

11,155

$514K

437
376 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $61

JEFFREY MORGAN MD

Internal Medicine

9,681

$691K

559
373 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $61

DEBRA LITZELMAN

Internal Medicine

1,322

$76.7K

53
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

EDWIN SHAKUN M.D.

Internal Medicine

550

$5,668

345
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$10
Average prescription price

Avg: $61

SYED ALI MD

Internal Medicine

10,358

$535K

318
253 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

STEVEN JOHNSON D.O.

Internal Medicine

1,433

$58.7K

155
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $61

VIDYA KORA MD

Internal Medicine

21,990

$1.14M

765
512 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

34%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

MARK TATARA MD

Internal Medicine

13,871

$894K

796
693 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank